NEW YORK (GenomeWeb News) – Bruker reported after the close of the market Thursday that its revenues in the first quarter were down 3 percent year over year, dropping to $393.4 million, compared to $405.6 million in Q1 2012.

The results fell short of the average Wall Street estimate of $417.0 million. Foreign currency effects were responsible for roughly half of that decline, the company said, with acquisitions and divestitures responsible for an additional net negative effect of a fraction of 1 percent.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.